SBC Medical Group Holdings Inc - Common Stock, $0.0001 par value per share (SBC) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
SBC on Nasdaq
Shares outstanding
101,625,000
Price per share
$4.63
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,319,022
Total reported value
$5,686,255
% of total 13F portfolios
0%
Share change
+470,151
Value change
+$2,024,801
Number of holders
41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SBC Medical Group Holdings Inc - Common Stock, $0.0001 par value per share (SBC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Aikawa Yoshiyuki 85% $404,682,650 87,404,460 Yoshiyuki Aikawa 06 Mar 2026
Aikawa Equity Management Co., Ltd. 5.2% $24,467,235 5,284,500 Aikawa Equity Management Co., Ltd. 06 Mar 2026

As of 31 Dec 2025, 41 institutional investors reported holding 1,319,022 shares of SBC Medical Group Holdings Inc - Common Stock, $0.0001 par value per share (SBC). This represents 1.3% of the company’s total 101,625,000 outstanding shares.

Institutional Holders of SBC Medical Group Holdings Inc - Common Stock, $0.0001 par value per share (SBC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,319,022 $5,686,255 +$2,024,801 $4.31 41
2025 Q3 847,633 $3,679,783 +$893,773 $4.34 41
2025 Q2 637,482 $2,957,757 +$2,553,652 $4.64 29
2025 Q1 90,282 $288,000 +$188,671 $3.19 4
2024 Q4 31,122 $173,039 +$116,990 $5.56 4
2024 Q3 17,600 $27,906 -$1,864,565 $7.95 3
2024 Q2 159,483 $1,898,077 -$843,445 $13.07 5
2024 Q1 224,645 $2,668,093 -$17,390,315 $12.51 5
2023 Q4 1,856,726 $19,778,158 +$518,116 $10.74 15
2023 Q3 1,808,221 $19,146,101 -$354,018 $10.68 13
2023 Q2 1,841,804 $18,811,533 -$85,949,884 $10.29 13
2023 Q1 10,193,077 $106,365,172 +$4,224,406 $10.44 38
2022 Q4 10,054,525 $102,703,072 +$40,929,304 $10.20 45
2022 Q3 5,529,910 $55,409,000 +$55,409,006 $10.02 21